Federation des caisses Desjardins du Quebec’s Calliditas Therapeutics AB American Depositary Shares CALT Stock Holding History
Bought
Maintained
Sold
Other funds holding CALT
BI
IIM
PCM
PCMC
Federation des caisses Desjardins du Quebec's CALT Position: Q2 2024 in Review
Federation des caisses Desjardins du Quebec sold out of Calliditas Therapeutics AB American Depositary Shares (CALT) in Q2 2024, closing a stake of 3,985 shares — an estimated $83.7K sold.
Federation des caisses Desjardins du Quebec first reported a position in CALT in Q2 2021 and held it in 12 quarters. The position peaked at $83.7K in Q1 2024. 18 funds tracked by Wall St. Rank hold CALT as of Q2 2024.
- Federation des caisses Desjardins du Quebec reported no remaining Calliditas Therapeutics AB American Depositary Shares position as of Q2 2024 after selling out during the quarter.
- Federation des caisses Desjardins du Quebec sold 3,985 Calliditas Therapeutics AB American Depositary Shares shares in Q2 2024, an estimated $83.7K.
- Federation des caisses Desjardins du Quebec first reported a position in Calliditas Therapeutics AB American Depositary Shares in Q2 2021 and held it in 12 quarters.
- Federation des caisses Desjardins du Quebec's Calliditas Therapeutics AB American Depositary Shares position peaked at $83.7K in Q1 2024.
- 18 funds tracked by Wall St. Rank held Calliditas Therapeutics AB American Depositary Shares as of Q2 2024.
Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2024, filed 14 Aug 2024.